SCHEMBL3237136

SCHEMBL3237136

CCCCn1cc2ccc(=O)cc-2c(C(=O)O)c1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 1/20 0.39
KDM4E B2RXH2 1/20 0.39
HSD17B10 Q99714 1/20 0.39
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
HDAC1 Q13547 2/20 0.36
HDAC6 Q9UBN7 2/20 0.36
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
BRD9 Q9H8M2 1/20 0.35
BRD4 O60885 2/20 0.35
GFER P55789 1/20 0.34
CNR2 P34972 2/20 0.34
ICMT O60725 2/20 0.33
ADORA3 P0DMS8 1/20 0.33
ADORA2B P29275 1/20 0.33
ADORA1 P30542 1/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3232124 0.86 HDAC1 (0.39) KDM4EHSD17B10MEN1KMT2AHDAC1
SCHEMBL3238452 0.84 BRD9 (0.36) MEN1KMT2AHDAC1HDAC6BRD9
SCHEMBL3242838 0.84 CASP3 (0.33) HDAC1HDAC6GFER
SCHEMBL3239397 0.84 ALDH1A1 (0.40) HSD17B10HDAC1HDAC6BRD4GFER
SCHEMBL3347259 0.81 PTGDR2 (0.46) KDM4EMEN1KMT2ABRD4PTGDR2
SCHEMBL3243476 0.80 ALDH1A1 (0.36) KDM4EMEN1KMT2ABRD9BRD4
SCHEMBL3236371 0.80 PTGDR2 (0.44) GFERPTGDR2
SCHEMBL3243756 0.79 BRD4 (0.36) KDM4EMEN1KMT2ABRD9BRD4
SCHEMBL3239111 0.79 KDM4E (0.32) KDM4EHSD17B10MEN1KMT2AHDAC1
SCHEMBL2311708 0.76 HSP90AA1 (0.35) PTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010028655-A1 ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS H. LUNDBECK A/S (DK) 2010-03-18 WO claimed
WO-2010028655-A1 ISOQUINOLINONE DERIVATIVES AS NK3 ANTAGONISTS H. LUNDBECK A/S (DK) 2010-03-18 WO disclosed